NCBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.76789702269298E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.99750224641571E-11 |
Normal-vs-Stage2 |
3.87010000000299E-05 |
Normal-vs-Stage3 |
2.16500151140053E-11 |
Normal-vs-Stage4 |
3.45150000002903E-06 |
Stage1-vs-Stage2 |
9.858600E-01 |
Stage1-vs-Stage3 |
2.154300E-02 |
Stage1-vs-Stage4 |
4.404200E-01 |
Stage2-vs-Stage3 |
1.558200E-01 |
Stage2-vs-Stage4 |
5.614800E-01 |
Stage3-vs-Stage4 |
5.482000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.11510031711271E-10 |
Normal-vs-AfricanAmerican |
5.17510034825364E-10 |
Normal-vs-Asian |
2.014600E-01 |
Caucasian-vs-AfricanAmerican |
6.871900E-02 |
Caucasian-vs-Asian |
2.995400E-01 |
AfricanAmerican-vs-Asian |
5.809600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.86960513316149E-11 |
Normal-vs-Female |
2.43230002805461E-09 |
Male-vs-Female |
9.902100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.07830000004328E-06 |
Normal-vs-Age(41-60Yrs) |
1.12249999961733E-07 |
Normal-vs-Age(61-80Yrs) |
7.9676265585249E-12 |
Normal-vs-Age(81-100Yrs) |
1.6030099999953E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.207400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.964400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.498400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.609620E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.320000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.570400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.623690E-02 |
Normal-vs-Grade 2 |
4.26190005509142E-09 |
Normal-vs-Grade 3 |
1.97564187232047E-12 |
Normal-vs-Grade 4 |
2.38959999998567E-06 |
Grade 1-vs-Grade 2 |
7.020400E-01 |
Grade 1-vs-Grade 3 |
2.497600E-01 |
Grade 1-vs-Grade 4 |
2.237400E-01 |
Grade 2-vs-Grade 3 |
3.720400E-02 |
Grade 2-vs-Grade 4 |
2.199600E-01 |
Grade 3-vs-Grade 4 |
8.194600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.76490000006291E-07 |
Normal-vs-ccB subtype |
2.91589974388273E-10 |
ccA subtype-vs-ccB subtype |
5.296000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.87900000400998E-08 |
Normal-vs-N1 |
6.357500E-03 |
N0-vs-N1 |
9.684400E-01 |
|
|